In addition, using a tissue-specific transgenic model, we demonstrate that cell type specific protein synthesis is essential for the maintenance of tumor heterogeneity in both basal and intermediate cells in the context of AR-low prostate cancer. This evidence concerns the gene AR and Familial prostate cancer.